Display options
Cite
Gutierrez-Hoffmann MG, O'Meally RN, Cole RN, et al. . Front Med (Lausanne). 2020;7:568doi: 10.3389/fmed.2020.00568.
Gutierrez-Hoffmann, M. G., O'Meally, R. N., Cole, R. N., Tiniakou, E., Darrah, E., & Soloski, M. J. (2020). . Frontiers in medicine, 7568. https://doi.org/10.3389/fmed.2020.00568
Gutierrez-Hoffmann, Maria G, et al. "." Frontiers in medicine vol. 7 (2020): 568. doi: https://doi.org/10.3389/fmed.2020.00568
Gutierrez-Hoffmann MG, O'Meally RN, Cole RN, Tiniakou E, Darrah E, Soloski MJ. . Front Med (Lausanne). 2020 Sep 16;7:568. doi: 10.3389/fmed.2020.00568. eCollection 2020. PMID: 33043033; PMCID: PMC7524959.
Copy Download .nbib Format: NLM
Share it on

Front Med (Lausanne). 2020 Sep 16;7:568. doi: 10.3389/fmed.2020.00568. eCollection 2020.

[No title available]

Frontiers in medicine

Maria G Gutierrez-Hoffmann, Robert N O'Meally, Robert N Cole, Eleni Tiniakou, Erika Darrah, Mark J Soloski

Affiliations

  1. Lyme Disease Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  2. Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  3. Mass Spectrometry and Proteomics Facility, Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

PMID: 33043033 PMCID: PMC7524959 DOI: 10.3389/fmed.2020.00568

Abstract

The MHC class II antigen processing and presentation pathway has evolved to derive short amino acid peptides from proteins that enter the endocytic pathway, load them onto MHC class II molecules and display them on the surface of antigen presenting cells for recognition by CD4

Copyright © 2020 Gutierrez-Hoffmann, O'Meally, Cole, Tiniakou, Darrah and Soloski.

Keywords: Borrelia; HLA-DR; MHC class II; dendritic cells; immunopeptidome

References

  1. Br J Cancer. 2002 May 6;86(9):1465-71 - PubMed
  2. J Virol. 2014 Oct;88(19):11045-55 - PubMed
  3. Arthritis Rheumatol. 2020 Mar 12;: - PubMed
  4. J Clin Invest. 2004 Apr;113(8):1093-101 - PubMed
  5. J Rheumatol. 2019 Aug;46(8):871-873 - PubMed
  6. PLoS One. 2014 Apr 16;9(4):e93243 - PubMed
  7. Annu Rev Immunol. 2016 May 20;34:265-97 - PubMed
  8. Science. 2006 Oct 20;314(5798):454-8 - PubMed
  9. JAMA. 2013 Sep 18;310(11):1110 - PubMed
  10. Nucleic Acids Res. 2009 Jan;37(1):1-13 - PubMed
  11. Clin Vaccine Immunol. 2016 Sep 06;23(9):757-66 - PubMed
  12. J Proteome Res. 2017 Jan 6;16(1):122-136 - PubMed
  13. Clin Immunol. 2015 Oct;160(2):336-41 - PubMed
  14. Clin Infect Dis. 2014 Feb;58(3):372-80 - PubMed
  15. Curr Opin Rheumatol. 2010 May;22(3):293-8 - PubMed
  16. Immunogenetics. 2008 Dec;60(12):759-65 - PubMed
  17. Trends Immunol. 2013 Nov;34(11):521-30 - PubMed
  18. J Leukoc Biol. 2004 Aug;76(2):314-21 - PubMed
  19. BMC Genomics. 2008 Oct 16;9:488 - PubMed
  20. Nat Rev Immunol. 2003 Dec;3(12):984-93 - PubMed
  21. Nat Protoc. 2009;4(1):44-57 - PubMed
  22. J Clin Invest. 2015 Jun;125(6):2228-33 - PubMed
  23. Autoimmun Rev. 2018 Sep;17(9):926-934 - PubMed
  24. N Engl J Med. 2001 Jul 12;345(2):115-25 - PubMed
  25. Clin Infect Dis. 2006 Nov 1;43(9):1089-134 - PubMed
  26. Nat Rev Immunol. 2013 Sep;13(9):679-92 - PubMed
  27. Front Immunol. 2018 Feb 21;9:104 - PubMed
  28. PLoS One. 2015 Mar 13;10(3):e0120744 - PubMed
  29. PLoS One. 2013 Dec 12;8(12):e80743 - PubMed
  30. Bioinformatics. 2009 Feb 15;25(4):555-6 - PubMed
  31. Immunology. 2018 Jul;154(3):394-406 - PubMed
  32. Arthritis Rheum. 2013 Jan;65(1):186-96 - PubMed
  33. J Infect Dis. 2015 Dec 1;212(11):1841-50 - PubMed
  34. J Immunol. 2002 Nov 1;169(9):5089-97 - PubMed
  35. Clin Exp Immunol. 2011 Jun;164(3):301-11 - PubMed
  36. Exp Cell Res. 2009 May 15;315(9):1584-92 - PubMed
  37. Front Immunol. 2017 Feb 23;8:95 - PubMed
  38. Annu Rev Immunol. 2017 Apr 26;35:469-499 - PubMed
  39. Arthritis Rheumatol. 2014 Sep;66(9):2313-23 - PubMed
  40. Nucleic Acids Res. 2012 Jul;40(Web Server issue):W281-7 - PubMed

Publication Types